Page last updated: 2024-09-05

erlotinib hydrochloride and gastrin-releasing peptide

erlotinib hydrochloride has been researched along with gastrin-releasing peptide in 1 studies

Compound Research Comparison

Studies
(erlotinib hydrochloride)
Trials
(erlotinib hydrochloride)
Recent Studies (post-2010)
(erlotinib hydrochloride)
Studies
(gastrin-releasing peptide)
Trials
(gastrin-releasing peptide)
Recent Studies (post-2010) (gastrin-releasing peptide)
4,3537863,0331,39218252

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fan, H; Grandis, JR; Lui, VW; Mills, GB; Siegfried, JM; Smithgall, TE; Thomas, SM; Xi, S; Zhang, Q1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and gastrin-releasing peptide

ArticleYear
Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation.
    Proceedings of the National Academy of Sciences of the United States of America, 2006, May-02, Volume: 103, Issue:18

    Topics: 3-Phosphoinositide-Dependent Protein Kinases; ADAM Proteins; ADAM17 Protein; Amphiregulin; Antineoplastic Agents; Cell Line; CSK Tyrosine-Protein Kinase; EGF Family of Proteins; ErbB Receptors; Erlotinib Hydrochloride; Gastrin-Releasing Peptide; Glycoproteins; Humans; Intercellular Signaling Peptides and Proteins; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Quinazolines; Recombinant Fusion Proteins; Signal Transduction; src-Family Kinases; Tumor Necrosis Factor-alpha

2006